July 03, 2018 Vicore Pharma and HealthCap create a leading drug development company focused on severe lung diseases
June 27, 2018 Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy
June 21, 2018 Nordic Nanovector Announces First Patient Dosed in Pivotal PARADIGME Trial of Betalutin® in Third-line Follicular Lymphoma Patients
June 20, 2018 Key Opinion Leaders highlight GS010 efficacy and patient benefits in discussion of findings from Reverse Phase III clincal trial
June 19, 2018 Targovax granted EU Patent for mutant-RAS neoantigen platform 2nd generation product TG02